Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
Clinical trial NCT04238624 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04238624
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-20
- Primary completion
- 2027-06-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.